{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:53:08Z","timestamp":1774529588342,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ijantimicag.2014.11.006","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T19:32:38Z","timestamp":1418326358000},"page":"262-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Long-term effects of an antimicrobial stewardship programme at a tertiary-care teaching hospital"],"prefix":"10.1016","volume":"45","author":[{"given":"Paul P.","family":"Cook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gooch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0005","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/665010","article-title":"Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)","volume":"33","author":"Society for Healthcare Epidemiology of America","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijantimicag.2012.10.013","article-title":"Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum \u03b2-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus","volume":"41","author":"Dancer","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0015","first-page":"CD003543","article-title":"Interventions to improve antibiotic prescribing practices for hospital inpatients","volume":"4","author":"Davey","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0020","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/jac\/dkh163","article-title":"Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram","volume":"53","author":"Cook","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jac\/dkq404","article-title":"Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital","volume":"66","author":"Cook","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0030","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/CCM.0b013e31828e9863","article-title":"Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome","volume":"41","author":"Rimawi","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jhm.2036","article-title":"The impact of penicillin skin testing on clinical practice and antimicrobial stewardship","volume":"8","author":"Rimawi","year":"2013","journal-title":"J Hosp Med"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0040","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhin.2006.06.033","article-title":"Effect of reduction in ciprofloxacin use on prevalence of meticillin-resistant Staphylococcus aureus rates within individual units of a tertiary-care hospital","volume":"64","author":"Cook","year":"2006","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jhin.2011.03.008","article-title":"Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis","volume":"78","author":"Parienti","year":"2011","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0050","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3201\/eid0911.030284","article-title":"Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients","volume":"9","author":"Weber","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0055","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/jac\/dkr555","article-title":"Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study","volume":"67","author":"Lafaurie","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jmii.2012.07.008","article-title":"Cost-effectiveness of a modified two-step algorithm using a combined glutamate dehydrogenase\/toxin enzyme immunoassay and real-time PCR for the diagnosis of Clostridium difficile infection","volume":"47","author":"Vasoo","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0065","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/cid\/cit492","article-title":"Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection","volume":"57","author":"Gould","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/cid\/cis840","article-title":"Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program","volume":"56","author":"Longtin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0075","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1086\/677151","article-title":"Clostridium difficile infections in Veterans Health Administration acute care facilities","volume":"35","author":"Evans","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0080","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1093\/jac\/dks330","article-title":"An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings","volume":"67","author":"Aldeyab","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0085","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1128\/AAC.00742-11","article-title":"Reduction in fluoroquinolone use following introduction of ertapenem to hospital formulary associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study","volume":"55","author":"Cook","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1128\/CMR.00001-13","article-title":"Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance","volume":"26","author":"Schechner","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0095","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1086\/664763","article-title":"Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive and intermediate care units","volume":"33","author":"Lewis","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0100","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.idc.2014.01.006","article-title":"Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges","volume":"28","author":"Ibrahim","year":"2014","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0195-6701(03)00088-4","article-title":"Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea","volume":"54","author":"Cunningham","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0115","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-136-11-200206040-00013","article-title":"The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, Gram-negative bacilli, Clostridium difficile, and Candida","volume":"136","author":"Safdar","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0120","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0125","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0130","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ijantimicag.2014.11.006_bib0140","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jamcollsurg.2008.12.025","article-title":"Active surveillance screening of MRSA and eradication of the carrier state decreases surgical-site infections caused by MRSA","volume":"208","author":"Pofahl","year":"2009","journal-title":"J Am Coll Surg"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791400363X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791400363X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T02:51:26Z","timestamp":1538016686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791400363X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S092485791400363X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.11.006","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effects of an antimicrobial stewardship programme at a tertiary-care teaching hospital","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}